CASC15, variants, traits, and what the research shows

CASC15 - what this gene does

CASC15 is a gene whose variants have been linked in population-level research to a range of trait categories. Based on the variants catalogued here, the gene shows associations spanning vision, respiratory, cardiovascular, liver, cancer, neurological, metabolic, pharmacogenomic, and rare disease phenotypes.

Key takeaways

• Variants in this gene are statistically associated with vision, respiratory, cardiovascular, and liver-related traits.
• Cancer susceptibility and neurological associations have also been observed at high-magnitude confidence levels.
• A pharmacogenomic variant suggests possible relevance to how some individuals respond to certain treatments.
• The liver-trait association appears in two independent variants, which is an early indicator of signal replication.
• All findings are population-level GWAS associations - not deterministic predictions for any individual.

Notable variants

The highest-magnitude signals in the dataset (score 4.50 - reflecting a composite of effect size and evidence strength) include rs10946491, linked to vision-related traits; rs2479808, associated with respiratory phenotypes; rs567753571, tied to cardiovascular traits; and rs6938097, linked to liver conditions. rs76088467 carries a cancer susceptibility signal, rs7763264 a neurological association, and rs78466540 a pharmacogenomic flag - all in the same magnitude tier. Among the lower-magnitude signals (2.80), rs4712652 is linked to metabolic traits, rs4712653 to liver conditions, and rs1341239 to rare disease phenotypes.

Trait associations

Across the curated variants, this gene's associations include: vision (rs10946491); respiratory conditions (rs2479808); cardiovascular phenotypes (rs567753571); liver-related traits, which appear in two independent variants (rs6938097 and rs4712653) - when a trait appears across multiple distinct variants, it can indicate a more robust signal; cancer susceptibility (rs76088467); neurological traits (rs7763264); pharmacogenomic phenotypes (rs78466540); metabolic traits (rs4712652); and rare disease categories (rs1341239).

Evidence quality

The strongest signals carry a magnitude score of 4.50 and span vision, respiratory, cardiovascular, liver, cancer, neurological, and pharmacogenomic categories. Lower-magnitude signals (2.80) cover metabolic, additional liver, and rare disease associations. The liver-trait category is the only one with apparent signal replication - two separate variants (rs6938097 and rs4712653) independently point to this trait, which modestly strengthens confidence in that association relative to the single-variant signals. Specific sample sizes and independent cohort replication data are not available in the current dataset; these findings should be treated as preliminary GWAS (genome-wide association study - a study that scans many people's genomes for variants statistically associated with a trait) signals until further validation is available.

What this is NOT

The variants described here are population-level statistical associations observed across research cohorts, not deterministic predictors of any health outcome for any individual. This content is informational only and does not constitute medical advice, a diagnosis, or a recommendation of any kind.